Surplus Asset Sales from Consolidation Project Nets Global Pharmaceutical Company Over $1.3 Million in 6 Months
A global biotech company wanted some visibility on their surplus assets. They were about to go through some huge changes; mergers and acquisition, some site closures. They really didn’t understand what they had. Implementing AssetZone®, Liquidity Services’ web-based program to monitor surplus, gave them clarity and efficiency, as well as a cost-effective program.
- Client Global Biotech Company
- Date February 9, 2015
- Tags Biopharmaceuticals